NASDAQ:ATRA - Atara Biotherapeutics, Inc.
$31.86
 $-0.72
-2.21%
4:00PM EDT
2019-04-18
Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for patients with severe and life-threatening diseases. The Company operates through the business of developing and commercializing therapeutics segment. The Company is focused on developing allogeneic or third-party derived antigen-specific T-cells. T-cells are a type of white blood cell. The Company's product candidate, ATA129, is a third-party derived Epstein-Barr virus CTL for the treatment of Epstein-Barr virus (EBV). ATA188 is in development for the treatment of multiple sclerosis. ATA520, which is a third-party donor derived WT1-CTL, targets cancers expressing the antigen Wilms Tumor 1 (WT1). ATA520 is in Phase I clinical trials. The Company's T-cell product candidate, ATA230, which is a third-party derived cytomegalovirus-CTL (CMV-CTL), is in Phase II clinical trials for refractory CMV. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ATRA     avg for
industry  
  avg for
sector  
42 stocks weight:  0. 19   203. 85   241. 91  
42 stocks rank:  4. 16 K 1. 44 K 1. 05 K
# analyst opinions:  6. 00   14. 51   13. 97  
mean recommendation:  2. 10   2. 09   2. 01  

quick ratio:  7. 75   5. 27   1. 81  
current ratio:  8. 04   5. 62   2. 25  

target price low:  23. 00   84. 80   115. 21  
target price avg:  47. 50   111. 51   137. 51  
target price high:  70. 00   135. 81   157. 84  
1-yr high:  51. 45   114. 23   138. 78  
last close:  31. 86   87. 66   116. 69  
50-day avg:  38. 13   95. 54   123. 44  
200-day avg:  37. 77   94. 25   121. 11  
1-yr low:  28. 40   72. 78   98. 34  
volume:  347. 66 K 4. 11 M 8. 07 M
50-day avg volume:  409. 70 K 2. 76 M 5. 02 M
200-day avg volume:  507. 15 K 2. 92 M 4. 59 M

1-day return:  -2. 21 % -0. 41 % 0. 07 %
this week return:  -11. 62 % -5. 74 % -4. 11 %
12-wk return:  -11. 33 % 1. 61 % -0. 05 %
52-wk return:  -18. 85 % 3. 12 % 8. 78 %

enterprise value (EV):  1. 21 B 48. 94 B 114. 64 B
market cap:  1. 47 B 43. 07 B 104. 73 B
EBITDA:  -233. 33 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -5. 17   4. 22   12. 73  
total debt:  10. 90 M 12. 24 B 16. 73 B
debt/equity:  3. 22   46. 71   89. 62  
net income (common):  -230. 70 M 2. 20 B 4. 20 B

shares outstanding:  46. 16 M 571. 70 M 1. 24 B
shares:  32. 80 M 571. 81 M 1. 23 B
shares short:  7. 15 M 10. 17 M 13. 00 M
shares short prior month:  7. 69 M 9. 54 M 17. 33 M
short ratio:  17. 33   5. 41   3. 28  
short % of float:  25. 75 % 5. 45 % 2. 38 %
total cash/share:  6. 71   11. 14   9. 33  
total cash:  309. 63 M 6. 71 B 7. 15 B
free cash flow:  -140. 05 M 3. 58 B 2. 96 B
operating cash flow:  -179. 77 M 4. 15 B 4. 30 B

book value:  7. 37   12. 78   26. 92  
price/book:  4. 32   3. 06   -1. 74  
operating margins:  0. 00 % -725. 35 % -89. 04 %
EBITDA margins:  0. 00 % 10. 94 % 22. 51 %
profit margins:  0. 00 % 7. 81 % 10. 57 %
gross margins:  0. 00 % 37. 08 % 55. 70 %

1-yr max volatility:  -19. 46 % --- ---
1-yr mean volatility:  -0. 01 % 0. 03 % 0. 04 %

1-yr EPS:  -5. 27   2. 40   4. 10  
forward EPS:  -5. 35   3. 97   7. 13  
P/E:  -6. 05   13. 63   22. 72  
forward P/E:  -5. 96   -15. 95   13. 99  
PE/G:  0. 58   -1. 65   -1. 32  
growth:  -10. 51 % 127. 12 % 29. 61 %
earnings high:  -1. 44   1. 00   1. 66  
earnings avg:  -1. 51   0. 77   1. 53  
earnings low:  -1. 61   0. 50   1. 39  
revenue high:  -0. 00   2. 68 B 10. 78 B
revenue avg:  -0. 00   2. 59 B 10. 57 B
revenue low:  -0. 00   2. 49 B 10. 36 B
return on assets:  -48. 62 % -2. 75 % 4. 55 %
return on equity:  -89. 29 % -18. 45 % 5. 46 %

beta (1yr vs S&P500):  2. 21   1. 25   0. 93  
sharpe (1yr):  -0. 04   0. 37   0. 70  

held % insiders:  4. 86 % 6. 39 % 3. 38 %
held % institutions:  111. 63 % 78. 14 % 68. 52 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-21 : ATRA
.    + 0.378 =         0.378 :: INITIAL WEIGHT
.   + 84.201 =        84.579 :: inverse volume-to-price addition
.   + 45.082 =       129.661 :: spline projection addition
.    x 2.467 =       319.926 :: 13 weeks' performance factor
.    x 0.882 =       282.087 :: one-year gains+dividend factor
.    x 1.431 =       403.786 :: industry recommendation factor
.    x 2.051 =       828.236 :: symbol recommendation factor
.    x 0.995 =        824.21 :: return on assets factor
.    x 0.991 =        816.85 :: return on equity factor
.     x 2.57 =      2099.546 :: current ratio factor
.    x 1.072 =      2249.807 :: quick ratio factor
.    x 1.028 =      2313.807 :: short ratio factor
.    x 2.043 =      4727.584 :: price-to-book factor
.    x 1.034 =      4887.656 :: debt-to-equity factor
.    x 1.009 =       4933.49 :: 50-day avg > 200-day avg
.    x 2.066 =     10193.096 :: P/E weight
.    x 1.148 =     11701.933 :: PE/G factor
.    x 1.312 =      15347.56 :: beta factor
.    x 0.038 =        575.83 :: sharpe factor
.    x 0.947 =       545.464 :: target low factor
.    x 1.234 =       672.855 :: target mean factor
.    x 1.109 =       746.474 :: target high factor
.     x 1.31 =       977.798 :: industry 2-weeks return factor
.    x 0.885 =       865.637 :: "drift" penalty 4 days ago
.    x 0.586 =        507.14 :: overall "drift" factor
.    x 0.999 =        506.73 :: largest single-day jump factor
.     x 1.01 =       511.797 :: mean volatility factor
.    x 1.097 =       561.404 :: 42-day mean volatility factor
.      x 1.0 =       561.313 :: factor hist industry gain for week 16
.   cubeRoot =         8.249 :: reduced to standardize
.   - 21.829 =         0.194 :: add/subtract for performance
.                      0.194 :: FINAL WEIGHT for NASDAQ:ATRA


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org